Challenges in CAR T-Cell Therapy for Lymphoma
Delve into the challenges of CAR T-cell therapy access and explore the biology behind treatment responses and relapses in lymphoma patients.
Source: onclive.com
Stay updated with breaking news from Relapse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Delve into the challenges of CAR T-cell therapy access and explore the biology behind treatment responses and relapses in lymphoma patients.
Investigator Jiten P. Kothadia, MD, discusses the advent of a predictive score for alcohol relapse risk in patients with alcohol liver disease who received a liver transplant in the last year.
How Suboxone clinics can help turn around someone's life.
Dr Gordon discusses use of bispecifics for management of patients with relapsing DLBCL.
Treatment of DLBCL amid comorbidities in elderly patients is highlighted.